Mammoth Biosciences develops CRISPR-based technologies for molecular diagnostics and programmable gene editing. The company leverages proprietary CRISPR systems and engineered Cas enzymes to create rapid, high-sensitivity diagnostic assays and platform capabilities for therapeutic discovery and precision genome manipulation.
Estimated Valuation
Leadership & Board
Current Number of Employees159
Current LinkedIn Followers59,372
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$95M
Total Amount Raised$95M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$95M
Latest Funding Amount$95M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Mammoth Biosciences had 159 employees as of October 5, 2026. The number of employees increased by 0 (0.00%) week-over-week.
159Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Mammoth Biosciences had 59,372 followers as of October 5, 2026. The number of followers increased by 46 (0.08%) week-over-week.
59,372Latest Followers Count
46(0.08%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
May 25, 2024
Investment
$95.00M
―
Investors
Investment
Similar Companies
A snapshot of private companies similar to Mammoth Biosciences, helping you discover and navigate related company profiles.
